Abstract: A retargeting advertisement service method according to an embodiment of the present invention includes collecting, by an advertisement targeting server, advertisement ID information and identification information from each of a plurality of terminals that have acquired an advertisement ID transmitted by a digital advertising medium, performing, by a bidding participation device, clustering using the information collected by the advertisement targeting server and transmitting information regarding a user group of a size exceeding a threshold, generated as a result of the clustering, to a bidding generation device, determining, by the bidding generation device, whether to generate real-time bidding (RTB) for a retargeting advertisement for the transmitted user group, based on the information regarding the transmitted user group, and performing, by the bidding participation device, the RTB when an advertisement media generation event occurs on a first terminal belonging to the user group.

Abstract: The present disclosure relates to a novel PLK1 degradation inducing compound, a method for preparing the same, and the use thereof. The compounds of the present disclosure exhibit an effect of inducing PLK1 degradation. Therefore, the compounds of the present disclosure may be effectively utilized for preventing or treating PLK1-related diseases.

Abstract: The present disclosure relates to a novel PLK1 degradation inducing compound, a method for preparing the same, and the use thereof. The compounds of the present disclosure exhibit an effect of inducing PLK1 degradation. Therefore, the compounds of the present disclosure may be effectively utilized for preventing or treating PLK1-related diseases.

Abstract: The present invention relates to NLRP3 protein degradation inducing compounds. Specifically, the present invention provides a bifunctional compound in which an NLRP3 protein binding moiety and an E3 ubiquitin ligase binding moiety are connected by a chemical linker, a method for preparing the same, a method for degrading NLRP3 protein using the same, and the use for preventing or treating NLRP3 inflammasome-related diseases.

Abstract: A method for collecting contents performed by a content collection device is provided. The method may comprise acquiring a captured image, recognizing a first object included in the acquired captured image by inputting the captured image into an object recognition model, the first object being an advertisement type object, generating content classification information for the recognized first object, determining whether the first object has already been reported by using the content classification information and transmitting metadata for the first object to a server when it is determined that the first object is a new object that has not already been reported as a result of performing the determining of whether the first object has already been reported.

Abstract: A method for displaying content of a mobility by identification of a riding target, performed by a display device provided in the mobility is provided. The method may comprise determining whether the mobility dispatched according to a call request of a user has entered within a critical distance with respect to a location specified by the user and displaying content related to a riding target on a screen of the display device when the riding target registered by the user is identified using an image sensor mounted on the mobility, when it is determined that the mobility has entered within the critical distance, wherein the riding target and the user are different.

Abstract: The present disclosure according to at least one embodiment provides a method for recommending a mission destination using urban data, the method being performed by a computing apparatus. The method comprises collecting urban data measured on a road partitioned into a plurality of unit areas, and generating a recommended destination for a mission vehicle based on the urban data and constraints set for performing a mission, wherein the recommended destination refers to one of the unit areas, and the mission is any one of a plurality of predetermined types of missions performed by the mission vehicle on a mission area on the road including the recommended destination and one or more adjacent areas of the recommended destination.

Abstract: A device and method use a heat source to generate heat energy and transfer the generated thermal energy to a plurality of electronic components in a non-contact manner through air to cause the plurality of electronic components to vibrate simultaneously. The device and method use a mechanical resonance detector to detect vibration resonances of the plurality of electronic components simultaneously. The device and method use a post-processing processor to compare the detected vibration resonances of the plurality of electronic components with a reference vibration resonance of a normal product to simultaneously determine whether the plurality of electronic components have defective electronic components.

Abstract: The present invention relates to a PLK1 protein degradation inducing compound, a preparation method thereof, and a use thereof. Compounds of the present invention target PLK1 and BRD4 to degrade PLK1, and decompose BRD4 to a suitable level within the scope of causing no side effects, and thus can be very advantageously used for prevention or treatment of cancer or neural disease.

Abstract: The present invention relates to a novel compound that induces selective degradation of AURKA, and specifically provides a bifunctional compound in which an AURKA binding moiety and an E3 ubiquitin ligase binding moiety are linked by a chemical linker, a method for preparing same, and a use thereof. In addition, the compound according to the present invention can be effectively used for the prevention or treatment of AURKA-related diseases.

Abstract: The present disclosure relates to a novel PLK1 degradation inducing compound having a structure according to Formula I, a method for preparing the same, and the use thereof. The compounds of the present disclosure exhibit an effect of inducing PLK1 degradation. Therefore, the compounds of the present disclosure may be effectively utilized for preventing or treating PLK1-related diseases.

Abstract: The present disclosure relates to a novel PLK1 degradation inducing compound having a structure according to Formula I, a method for preparing the same, and the use thereof. The compounds of the present disclosure exhibit an effect of inducing PLK1 degradation. Therefore, the compounds of the present disclosure may be effectively utilized for preventing or treating PLK1-related diseases.

Abstract: The present invention relates to a GPX4 protein degradation-inducing compound. Specifically, the present invention provides a bifunctional compound in which a GPX4 protein-binding moiety and a CRBN E3 ubiquitin ligase-binding moiety are linked by a chemical linker, a method for preparing the same, a method for degrading a GPX4 protein using the same, and the use for preventing or treating GPX4-related diseases or ferroptosis-related diseases.

Abstract: A floating offshore structure of the present disclosure includes: a plurality of columns; and a plurality of pontoons installed at lower ends of the columns, respectively, wherein a polygonal shape is formed by an imaginary line connecting the columns, the pontoons are installed inside the polygonal shape, a cross-sectional area in a direction parallel to sea level of the pontoons is greater than or equal to the cross-sectional area in the direction parallel to the sea level of the columns, and the pontoons may have a shape protruding outward at the lower ends of the columns.

Abstract: A floating offshore structure of the present invention comprises: a plurality of columns; and a tower support column for supporting a tower of a power generation structure, wherein a polygonal shape is formed by means of an imaginary line connecting the columns, and the tower supporting column can be provided at one point of one of the sides of the polygonal shape.

Abstract: The present invention provides novel compounds that induce selective polo-like kinase 1 (PLK1) degradation. Specifically, the present invention provides a bifunctional compound in which a PLK1 binding moiety and an E3 ubiquitin ligase-binding moiety are linked by a chemical linker. The present invention provides the compound, a method for preparing the same, and the use thereof. The compounds may be effectively utilized for preventing or treating PLK1 related diseases.

Abstract: The present invention provides novel compounds that induce selective polo-like kinase 1 (PLK1) degradation. Specifically, the present invention provides a bifunctional compound in which a PLK1 binding moiety and an E3 ubiquitin ligase-binding moiety are linked by a chemical linker. The present invention provides the compound, a method for preparing the same, and the use thereof. The compounds may be effectively utilized for preventing or treating PLK1 related diseases.

Abstract: The present disclosure relates to a novel PLK1 degradation inducing compound, a method for preparing the same, and the use thereof. The compounds of the present disclosure exhibit an effect of inducing PLK1 degradation. Therefore, the compounds of the present disclosure may be effectively utilized for preventing or treating PLK1-related diseases.

Abstract: The present disclosure relates to a novel PLK1 degradation inducing compound, a method for preparing the same, and the use thereof. The compounds of the present disclosure exhibit an effect of inducing PLK1 degradation. Therefore, the compounds of the present disclosure may be effectively utilized for preventing or treating PLK1-related diseases.

Abstract: The present invention provides novel compounds that induce selective polo-like kinase 1 (PLK1) degradation. Specifically, the present invention provides a bifunctional compound in which a PLK1 binding moiety and an E3 ubiquitin ligase-binding moiety are linked by a chemical linker. The present invention provides the compound, a method for preparing the same, and the use thereof. The compounds may be effectively utilized for preventing or treating PLK1 related diseases.